In France, distance from hospital and health care structure impact on outcome after arthroplasty of the hip for proximal fractures of the femur.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
09 Jun 2023
Historique:
received: 29 11 2022
accepted: 30 05 2023
medline: 12 6 2023
pubmed: 10 6 2023
entrez: 9 6 2023
Statut: epublish

Résumé

Hip arthroplasty is a frequently performed procedure in orthopedic surgery, carried out in almost all health structures for two main issues: fracture and coxarthrosis. Even if volume-outcome relationship appeared associated in many surgeries recently, data provided are not sufficient to set surgical thresholds neither than closing down low-volumes centers. With this study, we wanted to identify surgical, health care-related and territorial factors influencing patient' mortality and readmission after a HA for a femoral fracture in 2018 in France. Data were anonymously collected from French nationwide administrative databases. All patients who underwent a hip arthroplasty for a femoral fracture through 2018 were included. Patient outcome was 90-day mortality and 90-day readmission rate after surgery. Of the 36,252 patients that underwent a HA for fracture in France in 2018, 0.7% died within 90-day year and 1.2% were readmitted. Male and Charlson comorbidity index were associated with a higher 90-day mortality and readmission rate in multivariate analysis. High volume was associated with a lower mortality rate. Neither time of travel nor distance upon health facility were associated with mortality nor with readmission rate in the analysis. Even if volume appears to be associated with lower mortality rate even for longer distance and time of travel, the persistence of exogenous factors not documented in the French databases suggests that regionalization of hip arthroplasty should be organized with caution. As volume-outcome relationship must be interpreted with caution, policy makers should not regionalize such surgery without further investigation.

Sections du résumé

BACKGROUND BACKGROUND
Hip arthroplasty is a frequently performed procedure in orthopedic surgery, carried out in almost all health structures for two main issues: fracture and coxarthrosis. Even if volume-outcome relationship appeared associated in many surgeries recently, data provided are not sufficient to set surgical thresholds neither than closing down low-volumes centers.
QUESTION OBJECTIVE
With this study, we wanted to identify surgical, health care-related and territorial factors influencing patient' mortality and readmission after a HA for a femoral fracture in 2018 in France.
PATIENTS AND METHODS METHODS
Data were anonymously collected from French nationwide administrative databases. All patients who underwent a hip arthroplasty for a femoral fracture through 2018 were included. Patient outcome was 90-day mortality and 90-day readmission rate after surgery.
RESULTS RESULTS
Of the 36,252 patients that underwent a HA for fracture in France in 2018, 0.7% died within 90-day year and 1.2% were readmitted. Male and Charlson comorbidity index were associated with a higher 90-day mortality and readmission rate in multivariate analysis. High volume was associated with a lower mortality rate. Neither time of travel nor distance upon health facility were associated with mortality nor with readmission rate in the analysis.
CONCLUSION CONCLUSIONS
Even if volume appears to be associated with lower mortality rate even for longer distance and time of travel, the persistence of exogenous factors not documented in the French databases suggests that regionalization of hip arthroplasty should be organized with caution.
CLINICAL RELEVANCE CONCLUSIONS
As volume-outcome relationship must be interpreted with caution, policy makers should not regionalize such surgery without further investigation.

Identifiants

pubmed: 37296484
doi: 10.1186/s13018-023-03893-4
pii: 10.1186/s13018-023-03893-4
pmc: PMC10257255
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

418

Informations de copyright

© 2023. The Author(s).

Références

Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S149-S167
pubmed: 28756037
J Arthroplasty. 2021 Feb;36(2):579-585
pubmed: 32948425
J Am Coll Surg. 2009 Apr;208(4):599-606
pubmed: 19476796
BMJ. 2014 May 23;348:g3284
pubmed: 24859902
J Bone Joint Surg Am. 2016 May 4;98(9):707-12
pubmed: 27147682
J Gastrointest Surg. 2017 Mar;21(3):463-471
pubmed: 27813016
Health Serv Res. 2017 Apr;52(2):863-878
pubmed: 27198068
Ann Surg. 2018 Nov;268(5):854-860
pubmed: 30063493
Surgery. 2016 Jun;159(6):1528-1538
pubmed: 26897249
Ann Vasc Surg. 2018 Jul;50:154-159
pubmed: 29477676
J Clin Oncol. 2017 Aug 20;35(24):2772-2780
pubmed: 28682689
JBJS Rev. 2016 Dec 27;4(12):
pubmed: 28060788
Morphologie. 2018 Dec;102(339):231-242
pubmed: 30348489
Orthop Traumatol Surg Res. 2019 Feb;105(1S):S95-S101
pubmed: 30449680
Br J Surg. 2014 Apr;101(5):523-9
pubmed: 24615349
HPB Surg. 2008;2008:190914
pubmed: 19259261
J Gastrointest Surg. 2019 Jul;23(7):1425-1434
pubmed: 31069637
Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):954-962
pubmed: 28544284
Acta Orthop. 2019 Feb;90(1):26-32
pubmed: 30712501
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Br J Surg. 2017 Oct;104(11):1532-1538
pubmed: 28517236
Syst Rev. 2016 Nov 29;5(1):204
pubmed: 27899141
World J Surg Oncol. 2017 Jul 17;15(1):134
pubmed: 28716145
J Orthop Trauma. 2016 Nov;30(11):597-604
pubmed: 27769073
J Rural Health. 2004 Fall;20(4):344-54
pubmed: 15551851
J Clin Oncol. 2009 Oct 1;27(28):4671-8
pubmed: 19720926
Clin Orthop Relat Res. 2016 Feb;474(2):357-64
pubmed: 26040966
Ann Surg. 2018 Nov;268(5):799-807
pubmed: 30048329
Urology. 2018 Apr;114:87-94
pubmed: 29305205
Ann Surg. 2016 Nov;264(5):823-830
pubmed: 27429033
J Gastrointest Surg. 2019 May;23(5):944-952
pubmed: 30815777
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Surgery. 2013 Nov;154(5):1100-9
pubmed: 24075275
BMC Musculoskelet Disord. 2016 Nov 9;17(1):463
pubmed: 27829422

Auteurs

Mathieu Levaillant (M)

Univ. Lille, CHU Lille, ULR 2694 - METRICS : Évaluation des technologies de santé et des pratiques médicales, 59000, Lille, France. mathieu.levaillant@gmail.com.
Centre Hospitalier Universitaire d'Angers, Angers, France. mathieu.levaillant@gmail.com.

Louis Rony (L)

Centre Hospitalier Universitaire d'Angers, Angers, France.

Jean-François Hamel-Broza (JF)

Centre Hospitalier Universitaire d'Angers, Angers, France.
University Angers, Angers, France.

Julien Soula (J)

Univ. Lille, CHU Lille, ULR 2694 - METRICS : Évaluation des technologies de santé et des pratiques médicales, 59000, Lille, France.

Benoît Vallet (B)

Univ. Lille, CHU Lille, ULR 2694 - METRICS : Évaluation des technologies de santé et des pratiques médicales, 59000, Lille, France.

Antoine Lamer (A)

Univ. Lille, CHU Lille, ULR 2694 - METRICS : Évaluation des technologies de santé et des pratiques médicales, 59000, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH